Bendamustine hydrochloride
Jump to navigation
Jump to search
| Bendamustine hydrochloride | |
|---|---|
| Term | Bendamustine hydrochloride |
| Short definition | Bendamustine hydrochloride - (pronounced) (BEN-duh-MUS-teen HY-threatening-KLOR-ide) A drug used to treat chronic lymphocytic leukemia and certain types of non-Hodgkin's lymphoma. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Bendamustine hydrochloride - (pronounced) (BEN-duh-MUS-teen HY-threatening-KLOR-ide) A drug used to treat chronic lymphocytic leukemia and certain types of non-Hodgkin's lymphoma. It is also being studied in the treatment of other types of cancer. Bendamustine hydrochloride damages the cell's DNA and can kill cancer cells. It's a type of alkylating agent. Also called Belrapzo, Bendeka and Treanda
External links
- Medical encyclopedia article on Bendamustine hydrochloride
- Wikipedia's article - Bendamustine hydrochloride
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski